Tests mebendazole with chemotherapy in adults with colorectal cancer
Tests mebendazole added to chemotherapy in adults with colorectal cancer.
Plain-language title generated from the registry record
Registry title: Mebendazole as Adjuvant Treatment for Colon Cancer
Key facts
- Where
- Cairo, EgyptSee the site
- Phase
- Phase 3
AI summary: who the study is looking for
From the trial's eligibility criteria. Machine-read from the registry text on this page, so it can be wrong. The registry text below and the trial team decide who can take part.
The trial is looking for adults with stage 4 colorectal cancer. It tests mebendazole as an add-on to the usual treatment.
- Age
- 18 years and older
- Sex
- Women and men can join
- Disease stage
- Colorectal cancer, stage 4
Main reasons for not taking part
- Agranulocytosis
- Pregnancy
- Allergy to mebendazole
Read by machine on 9 November 2026.
Where in Egypt
- Sherief Abd-ElsalamCairo, EgyptTaking people
Questions to ask the study team
- How often do I need to come in, and for how long each time?
- Are travel costs paid?
- Can I keep my own doctor?
- What happens if I want to stop?
Trial details
- Who runs it
- Sherief Abd-Elsalam
- Trial code
- NCT03925662
- Record updated
- 24 April 2019
- Original description
mebendazole treating colon cancerRead full original descriptionShow less
Clinical Study Evaluating Mebendazole as Adjuvant Therapy in Patients With Colorectal Cancer
mebendazole treating colon cancer
Inclusion: Colorectal cancer stage 4.
Exclusion: Allergy to mebendazole; Agranulocytosis; Pregnancy.